MSB 7.69% $1.19 mesoblast limited

Ann: FDA Advisory Committee Sets Review Date for Remestemcel-L, page-307

  1. 3,999 Posts.
    lightbulb Created with Sketch. 315
    I totally agree
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.